Toray Industries Aktie
5,58EUR | 0,06EUR | 1,05% |
WKN: 853974 / ISIN: JP3621000003
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 82,27 |
Nippon Life Insurance Co. | 6,57 |
BlackRock Fund Advisors | 2,77 |
Nomura Asset NEXT FUNDS TOPIX ETF (1306) | 2,63 |
Toray Industries, Inc. | 1,78 |
National Mutual Insurance Fed. of Agricultural Cooperatives | 1,63 |
BlackRock Japan Co. Ltd. | 1,63 |
Sumitomo Mitsui Financial Group, Inc. | 1,47 |
Vanguard Total International Stock Index Fund | 1,30 |
Nikko Asset Listed Index TOPIX ETF (1308) | 1,27 |
Mitsui Fudosan Co., Ltd. | 1,19 |
Daiwa Asset iFreeETF TOPIX (Yearly Dividend Type) (1305) | 1,19 |
Mitsui & Co., Ltd. | 0,84 |
Vanguard Developed Markets Index Fund | 0,79 |
MS&AD Insurance Group Holdings, Inc. | 0,72 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 48 031 | 46 267 | 48 842 | 48 682 | 48 140 |
Umsatz pro Mitarbeiter in Mio. EUR | 46,11 | 40,71 | 45,63 | 51,13 | 51,20 |
Bilanz (in Mio. JPY) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 1 128 452 | 1 181 039 | 1 373 236 | 1 429 279 | 1 522 640 |
Summe Anlagevermögen | 1 522 235 | 1 667 800 | 1 670 645 | 1 764 762 | 1 943 878 |
Summe Aktiva | 2 650 687 | 2 848 839 | 3 043 881 | 3 194 041 | 3 466 518 |
Bilanz (in Mio. JPY) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 938 913 | 973 927 | 935 658 | 950 093 | 949 684 |
Summe Fremdkapital | 1 471 115 | 1 526 564 | 1 544 232 | 1 558 231 | 1 620 156 |
Summe Eigenkapital | 1 179 572 | 1 322 275 | 1 499 649 | 1 635 810 | 1 846 362 |
Summe Passiva | 2 650 687 | 2 848 839 | 3 043 881 | 3 194 041 | 3 466 518 |
Adresse
Nihonbashi Mitsui Tower, 103-8666 Tokyo | |
Telefon | +81 (3) 3245-5201 |
Fax | +81 (3) 3245-5054 |
Internet | http://www.toray.co.jp |
Management
Akihiro Nikkaku
Chairman |
Hideki Hirabayashi
Auditor |
Hiroyuki Matsuda
Manager-Information Systems Department |
Jun Hayakawa
General Manager-Pharmaceuticals |
Kazuhiko Shutou
Director, Executive Officer & Vice President |
Kazuo Futagawa
Independent Outside Director |
Kazuyuki Adachi
Director, Executive Officer & Vice President |
Kunio Ito
Independent Outside Director |
Masahiko Okamoto
Director, Manager-Finance & Accounting Division |
Mitsuo Ohya
President, CEO & Representative Director |
Ryoji Noyori
Independent Outside Director |
Satoru Hagiwara
Representative Director & Vice President |
Shigeki Taniguchi
Manager-Communication Division |
Susumu Kaminaga
Independent Outside Director |
Tetsuya Tsunekawa
Director & Senior Managing Executive Officer |
Yanai Katsuyuki
Manager-Human Resources Department |
Yoshiro Yamamoto
Manager-Legal & Compliance Department |
Yoshiyuki Tanaka
Auditor |
Yuko Harayama
Independent Outside Director |
Yusuke Tsuzuki
Manager-Marketing & Corporate Planning Office |